MarketPulse

class action lawsuit

1932 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Snowflake Faces Securities Fraud Class Action Over Undisclosed Business Headwinds

Robbins Geller launches class action lawsuit against $SNOW, alleging securities fraud over false product efficiency claims and material business disclosures between June 2023 and February 2024.
SNOWBSXEOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Boston Scientific Faces Securities Fraud Lawsuit as Stock Plunges 17% on Guidance Miss

Three companies face class action lawsuits alleging securities fraud. Boston Scientific stock fell 17% after missing earnings guidance amid alleged false revenue projections.
SNOWBSXEOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Four Companies Face Shareholder Lawsuits Over Alleged Disclosure Failures

Four companies face April 6, 2026 lead plaintiff deadline in shareholder lawsuits alleging disclosure violations involving valuations, clinical trials, and fraudulent promotion.
TCPCMREORAREPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Investors Face April 3 Deadline in Class Actions Against $PLUG, PMI, and $RR

Law firm issues April 3, 2026 deadline reminder for lead plaintiff status in class actions against Plug Power, Picard Medical, and Richtech Robotics alleging material misstatements.
RRPLUGPMIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Navan Faces Securities Lawsuit Over Concealed Marketing Spending Surge

Navan investors sue over allegedly misleading IPO disclosures. Stock crashed 63% after surprise 39% sales expense hike revealed.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Driven Brands Faces Class Action Over $DRVN Financial Restatement; Stock Plummets 40%

Driven Brands ($DRVN) faces class action lawsuit over accounting errors in fiscal 2023-2025 statements. Stock fell 40% after February disclosure. Investors can seek lead plaintiff status.
DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

America's Car-Mart Stock Plunges 18% After Surprise Loss; Securities Probe Launched

America's Car-Mart stock plunges 18% after reporting unexpected quarterly loss; securities investigation launched over alleged misleading disclosures.
CRMTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Navan Hit With Securities Suit Over IPO Disclosure Claims

Class action lawsuit filed against $NAAM alleges October 2025 IPO prospectus contained false statements about sales and marketing expenses. Lead plaintiff deadline: April 24, 2026.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Eos Energy Investors Face May 2026 Deadline in Securities Class Action

Rosen Law Firm pursues class action against Eos Energy Enterprises for alleged false statements about operations and guidance. Investors must act by May 5, 2026 deadline.
SMREOSENKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

ODDITY Tech Stock Crashes 49% After Disclosure of Hidden Ad Partner Algorithm Changes

ODDITY Tech faces class action lawsuit alleging concealment of ad partner algorithm changes that inflated customer acquisition costs. Stock fell 49% after CEO disclosure on February 25.
ODDsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

Soleno Therapeutics Faces Securities Fraud Suit Over DCCR Drug; Deadline Looms

Soleno Therapeutics ($SLNO) faces securities fraud lawsuit over DCCR drug for Prader-Willi syndrome. Stock plunged following safety concerns, patient death, and weak Q3 results.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Lawsuits Target Nektar, Enphase Over Alleged False Statements

Rosen Law Firm files securities class actions against Nektar Therapeutics, Enphase Energy, and Aquestive Therapeutics. Investors have until May 5, 2026 to join.
ENPHAQSTNKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Lawsuit Filed Against Aquestive Therapeutics Over Alleged Securities Violations

Rosen Law Firm filed class action against Aquestive Therapeutics alleging false statements about product development and regulatory matters. Eligible investors should act before deadline.
ENPHAQSTNKTRsecurities fraudclass action lawsuit
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

Paysafe Faces Securities Fraud Lawsuit Over Undisclosed Client Exposure

Law firm files class action against $PSFE alleging disclosure failures on high-risk client exposure and credit reserves between March-November 2025.
PSFEsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

DRVN Plummets 30% After Accounting Restatement; Class Action Deadline Looms

Driven Brands ($DRVN) stock plummets 30.2% after disclosing multi-year accounting errors. Class action deadline set for May 8, 2026.
DRVNsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

Camping World Faces Securities Fraud Lawsuit Over Inventory and Demand Misstatements

Class action lawsuit filed against $CWH for allegedly making false statements about business operations. Stock fell 24.8% and 16.5% in two separate drops.
CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Mereo BioPharma Faces Class Action Over Failed Clinical Trials and Investor Losses

Class action lawsuit filed against Mereo BioPharma over alleged misstatements regarding failed Phase 3 clinical trials. Investors have until April 6, 2026, to join.
MREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Corcept Therapeutics Faces Class Action Over Relacorilant Clinical Trial Claims

Class action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Ramaco Resources Faces Class Action Over Alleged Brook Mine Misrepresentations

Class action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate.
METCMETCBMETCIMETCZsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nektar Therapeutics Faces Class Action Over Misleading Trial Data Claims

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value.
NKTRsecurities fraudclass action lawsuit